Treatment advances in TNBC

Plenary Lecture Dr. Melinda Telli, MD: Recent Advances in Triple Negative Breast CancerПодробнее

Improving Our Understanding of TNBC to Advance Health EquityПодробнее

HR status in determining the efficacy of platinum therapy in advanced TNBCПодробнее

Near Complete Remission in Stage 4 Triple Negative Breast Cancer | #integrativeoncology | AOHCПодробнее

TROP2-Targeting ADCs as New Tools in the TNBC and HR+/HER2- Breast Cancer Treatment ArsenalПодробнее

Breast Cancer Breakout: Rapid research developments and new treatment combinationsПодробнее

Recent advances in targeted therapies for TNBCПодробнее

Triple-negative breast cancer: a potential new treatment is now in sightПодробнее

Expert report on treatment with Tumour-Infiltrating Lymphocytes (TILs)Подробнее

BEGONIA: durvalumab + dato-DXd in advanced TNBCПодробнее

Understanding Triple-Negative Breast Cancer | Dr. Devavrat Arya | Max Hospital, SaketПодробнее

2021 San Antonio Breast Cancer Symposium Update on MBC | 2021-2022 EMBRACE MBC Virtual Forum SeriesПодробнее

What is Triple-Negative Breast Cancer, and How is it Treated?Подробнее

Expanding the Benefits of Checkpoint Inhibitors and Targeted Agents in Triple-Negative Breast CancerПодробнее

Treatment Options for Triple-Negative Breast Cancer Prof. Peter SchmidПодробнее

The role of immunotherapy in advanced TNBC Prof. Peter SchmidПодробнее

Encouraging developments in triple negative breast cancer immunotherapyПодробнее

2021 West Oncology | Breast Cancer | New Advances for Metastatic TNBCПодробнее

Advances in Treatment of Triple-Negative Breast Cancer: A Success StoryПодробнее